NO20015105L - Nytt farmasöytisk preparat - Google Patents

Nytt farmasöytisk preparat

Info

Publication number
NO20015105L
NO20015105L NO20015105A NO20015105A NO20015105L NO 20015105 L NO20015105 L NO 20015105L NO 20015105 A NO20015105 A NO 20015105A NO 20015105 A NO20015105 A NO 20015105A NO 20015105 L NO20015105 L NO 20015105L
Authority
NO
Norway
Prior art keywords
pharmaceutical preparation
new pharmaceutical
new
preparation
pharmaceutical
Prior art date
Application number
NO20015105A
Other languages
English (en)
Other versions
NO20015105D0 (no
NO320573B1 (no
Inventor
Paul David James Blackler
Andrew Simon Craig
Robert Gordon Giles
Michael John Sasse
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20015105D0 publication Critical patent/NO20015105D0/no
Publication of NO20015105L publication Critical patent/NO20015105L/no
Publication of NO320573B1 publication Critical patent/NO320573B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NO20015105A 1999-04-20 2001-10-19 Hydroklorid-hydrater, anvendelse og fremstilling derav, samt farmasoytisk preparat. NO320573B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9909075.5A GB9909075D0 (en) 1999-04-20 1999-04-20 Novel pharmaceutical
PCT/GB2000/001527 WO2000063206A2 (en) 1999-04-20 2000-04-19 Thiazolidinedione derivative and its use as antidiabetic

Publications (3)

Publication Number Publication Date
NO20015105D0 NO20015105D0 (no) 2001-10-19
NO20015105L true NO20015105L (no) 2001-12-19
NO320573B1 NO320573B1 (no) 2005-12-27

Family

ID=10851922

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20015105A NO320573B1 (no) 1999-04-20 2001-10-19 Hydroklorid-hydrater, anvendelse og fremstilling derav, samt farmasoytisk preparat.

Country Status (42)

Country Link
EP (2) EP1173437B1 (no)
JP (2) JP4283450B2 (no)
KR (1) KR100677815B1 (no)
CN (2) CN1327446A (no)
AP (1) AP1680A (no)
AR (2) AR023563A1 (no)
AT (1) ATE262524T1 (no)
AU (1) AU773112B2 (no)
BG (1) BG65428B1 (no)
BR (1) BR0009898A (no)
CA (1) CA2370270A1 (no)
CO (1) CO5170420A1 (no)
CZ (1) CZ300934B6 (no)
DE (1) DE60009276T2 (no)
DK (1) DK1173437T3 (no)
DZ (1) DZ3163A1 (no)
EA (1) EA004769B1 (no)
EG (1) EG23946A (no)
ES (1) ES2214267T3 (no)
GB (1) GB9909075D0 (no)
HK (1) HK1045304B (no)
HR (1) HRP20010771B1 (no)
HU (1) HUP0200785A3 (no)
IL (1) IL146077A0 (no)
MA (1) MA26784A1 (no)
MX (1) MXPA01010695A (no)
MY (1) MY125209A (no)
NO (1) NO320573B1 (no)
NZ (1) NZ515164A (no)
OA (1) OA11867A (no)
PE (1) PE20010047A1 (no)
PL (1) PL351115A1 (no)
PT (1) PT1173437E (no)
RS (1) RS50137B (no)
SI (1) SI1173437T1 (no)
SK (1) SK284990B6 (no)
TR (1) TR200103041T2 (no)
TW (1) TWI291463B (no)
UA (1) UA72245C2 (no)
UY (1) UY26113A1 (no)
WO (1) WO2000063206A2 (no)
ZA (1) ZA200108721B (no)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical
GB0006133D0 (en) 2000-03-14 2000-05-03 Smithkline Beecham Plc Novel pharmaceutical
GB0014005D0 (en) * 2000-06-08 2000-08-02 Smithkline Beecham Plc Novel pharmaceutical
JP2005513038A (ja) * 2001-11-21 2005-05-12 スミスクライン　ビーチャム　パブリック　リミテッド　カンパニー ５−［４−［２−（ｎ−メチル−ｎ−（２−ピリジル）アミノ）エトキシ］ベンジル］チアゾリジン−２，４−ジオンベンゼンスルホン酸塩；その製造方法；多形体ｉ、ｉｉおよびｉｉｉ；および医薬上活性な成分としてのその使用
KR100450700B1 (ko) * 2002-03-22 2004-10-01 주식회사종근당 티아졸리딘디온 유도체 화합물 및 이를 함유하는 약제학적조성물
CZ298424B6 (cs) * 2005-05-24 2007-09-26 Zentiva, A. S. Zpusob krystalizace rosiglitazonu a jeho derivátuze smesných rozpouštedel
EP1842850A1 (en) * 2006-03-23 2007-10-10 Sandoz AG Rosiglitazone hydrochloride hemihydrate

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3856378T2 (de) * 1987-09-04 2000-05-11 Beecham Group Plc Substituierte Thiazolidindionderivate
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds
GB9909075D0 (en) * 1999-04-20 1999-06-16 Smithkline Beecham Plc Novel pharmaceutical

Also Published As

Publication number Publication date
CZ20013758A3 (cs) 2003-05-14
SK284990B6 (sk) 2006-04-06
EA004769B1 (ru) 2004-08-26
DE60009276T2 (de) 2004-08-26
MXPA01010695A (es) 2002-06-04
EG23946A (en) 2008-01-22
ES2214267T3 (es) 2004-09-16
BG65428B1 (bg) 2008-07-31
AU4131100A (en) 2000-11-02
TWI291463B (en) 2007-12-21
AP1680A (en) 2006-11-27
CO5170420A1 (es) 2002-06-27
CN1327446A (zh) 2001-12-19
EP1411054A1 (en) 2004-04-21
BR0009898A (pt) 2002-04-16
GB9909075D0 (en) 1999-06-16
TR200103041T2 (tr) 2002-03-21
DK1173437T3 (da) 2004-07-12
DZ3163A1 (fr) 2000-10-26
SK14892001A3 (sk) 2002-02-05
HK1045304B (zh) 2004-12-24
CA2370270A1 (en) 2000-10-26
IL146077A0 (en) 2002-07-25
EP1173437A2 (en) 2002-01-23
HRP20010771B1 (en) 2005-06-30
WO2000063206A2 (en) 2000-10-26
NO20015105D0 (no) 2001-10-19
NO320573B1 (no) 2005-12-27
MY125209A (en) 2006-07-31
UA72245C2 (uk) 2005-02-15
CZ300934B6 (cs) 2009-09-16
WO2000063206A3 (en) 2001-02-22
AR023563A1 (es) 2002-09-04
CN101125851A (zh) 2008-02-20
AU773112B2 (en) 2004-05-20
KR100677815B1 (ko) 2007-02-05
PT1173437E (pt) 2004-06-30
AR023567A1 (es) 2002-09-04
YU81601A (sh) 2004-09-03
SI1173437T1 (en) 2004-06-30
KR20010112446A (ko) 2001-12-20
EP1173437B1 (en) 2004-03-24
JP2002542243A (ja) 2002-12-10
HUP0200785A3 (en) 2004-03-29
ZA200108721B (en) 2002-09-13
ATE262524T1 (de) 2004-04-15
UY26113A1 (es) 2000-12-29
RS50137B (sr) 2009-03-25
HUP0200785A2 (en) 2002-08-28
JP2009161544A (ja) 2009-07-23
PE20010047A1 (es) 2001-03-10
DE60009276D1 (de) 2004-04-29
JP4283450B2 (ja) 2009-06-24
EA200101102A1 (ru) 2002-04-25
PL351115A1 (en) 2003-03-24
MA26784A1 (fr) 2004-12-20
BG106120A (en) 2002-05-31
AP2001002332A0 (en) 2001-12-31
HK1045304A1 (en) 2002-11-22
OA11867A (en) 2006-03-02
NZ515164A (en) 2004-02-27
HRP20010771A2 (en) 2002-12-31

Similar Documents

Publication Publication Date Title
NO20030418D0 (no) Nytt farmasöytisk preparat
NO20033143L (no) Farmasoytisk preparat
NO20015175L (no) Farmasöytisk sammensetning
FI991485A (fi) Uusi farmaseuttinen koostumus
NO20005399D0 (no) Farmasøytisk preparat
DE60038698D1 (de) Hydrogel-gesteuerte dosierungsform
PT1242087E (pt) Composicoes farmaceuticas
NO20015149L (no) Nytt farmasöytisk preparat
EE200200150A (et) Preparaat
DK1466615T3 (da) Farmaceutisk præparat
NO20015670L (no) Forbedrede farmasöytiske formuleringer
NO20022606D0 (no) Farmasöytiske kombinasjoner
NO20015148D0 (no) Nytt farmasöytisk preparat
NO20025805D0 (no) Farmasöytisk preparat
NO20014926D0 (no) Farmasöytiske forbindelser
PT1239832E (pt) Composicoes farmaceuticas
NO20015104D0 (no) Nytt farmasöytisk preparat
FI4488U1 (fi) Farmaseuttinen koostumus
NO20015105D0 (no) Nytt farmasöytisk preparat
AR025867A1 (es) Formulacion portasdora farmaceutica
NO20016430L (no) Farmasöytisk kompleks
NO20021036D0 (no) Farmasöytisk preparat
NO20004816D0 (no) Ny farmasøytisk formulering
NO20022541D0 (no) Fast preparat
NO20014450D0 (no) Farmasöytisk preparat basert på polyaromatiske forbindelser

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees